USPTO serial 79285462
OPTIMAPHARM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEINPFAD, SARAH E
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OPTIMAPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James N Palik
Unit 2163 Woodward BlvdTulsa, OK 74114Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Corporate communications services, namely, providing consultation regarding public relations communication strategies to businesses; organization of exhibitions for commercial or advertising purposes; organization of trade fairs; distribution of samples, advertising by mail order, rental of advertising time on communication media; wholesale store services for pharmaceutical, veterinary and medical preparations and supplies, retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; drawing up of statements of accounts, namely, preparation of financial statements; business auditing, compilation of information into computer databases, systemization of information into computer databases; psychological testing for the selection of personnel; human resources consultancy, personnel recruitment; billing; updating and maintenance of data in computer databases; photocopying services; appointment scheduling services [office functions], business management consultancy, business management and organization consultancy, business organization consultancy, professional business consultancy, advisory services for business management; rental of office machines and equipment | ACTIVE | — |
| 041 | Electronic publishing services, namely, publication of text and graphic works of others on recorded media and on-line featuring medical research publication of books; publication of texts, other than publicity texts; providing online publications in the nature of electronic books and journals in the field of diseases and medical and pharmaceutical research providing online electronic publications, not downloadable in the nature of diseases and medical and pharmaceutical in the field of diseases and medical and pharmaceutical research; news reporters services | ACTIVE | — |
| 042 | Technical writing; data security consultancy; research and development of new products for others; technical research in the field of pharmaceutical studies, conducting clinical trials for others [conducting], research related to pharmaceuticals, research on the subject of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the pharmaceutical and biotechnology fields, clinical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders consultancy relating to research and development in the field of therapeutics, consultancy relating to laboratory testing, consultancy in the field of pharmaceutical research, calibration services relating to medical apparatus, research and development of vaccines and medicines, pharmaceutical products research, testing of pharmaceuticals, consultancy relating to pharmacology, pharmaceutical drug development services, biological research, clinical and medical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders, medical research, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical product evaluation, conducting clinical trials for others for pharmaceutical products, conducting clinical trials for others in the field of cardiovascular disease, conducting clinical trials for others, provision of information and data relating to medical and veterinary research and development, providing information about the results of clinical trials for pharmaceutical products, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing scientific information in the field of medical disorders and their treatment, development of pharmaceutical preparations and medicines, pharmaceutical products development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 11, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 11, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 8, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 20, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 20, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 11, 2021 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 11, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 25, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 25, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 25, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 28, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 27, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 14, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |